Med Fusion HemeSEQ Profiles

Med Fusion has launched an expansion of its oncology testing services to include HemeSEQ portfolio of next-generation sequencing profiles. The profiles cover four hematologic neoplasms: Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, and Myeloproliferative Neoplasms. These profiles expand the company's hematologic testing menu to nearly 100 tests and incorporate next-generation sequencing technology. Customer tests results are matched with relevant clinical trials and therapy options based on the specific genomic signature of the patient's disease, the company said. The final report is easy to read and delivers oncologists a powerful tool to access diagnosis and prognosis of patients living with hematologic disease.